Benjamin Purow

Notch-1 regulates transcription of the epidermal growth factor receptor through p53.

Advances in the genetics of glioblastoma: are we reaching critical mass?

The elephant in the room: do microRNA-based therapies have a realistic chance of succeeding for brain tumors such as glioblastoma?

Spirituality and pediatric cancer.

Notch inhibition as a promising new approach to cancer therapy.

A miR-297/hypoxia/DGK-α axis regulating glioblastoma survival.

Neuro-oncology: Five new things.

Molecular Pathways: Targeting Diacylglycerol Kinase Alpha in Cancer.

Interstitial flow differentially increases patient-derived glioblastoma stem cell invasion via CXCR4, CXCL12, and CD44-mediated mechanisms.

Dual activities of ritanserin and R59022 as DGKα inhibitors and serotonin receptor antagonists.

The Ligand Binding Landscape of Diacylglycerol Kinases.

Combined CDK4/6 and mTOR Inhibition Is Synergistic against Glioblastoma via Multiple Mechanisms.

Deconstructing Lipid Kinase Inhibitors by Chemical Proteomics.

Checkpoint inhibitor failure in hypermutated and mismatch repair-mutated recurrent high-grade gliomas.

Technical choices significantly alter the adaptive immune response against immunocompetent murine gliomas in a model-dependent manner.

Identification of ritanserin analogs that display DGK isoform specificity.

A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma.

Microenvironment T-Type calcium channels regulate neuronal and glial processes to promote glioblastoma growth.